Web Results

caselaw.findlaw.com/ca-court-of-appeal/1211311.html

Court of Appeal, First District, Division 2, California. James CLAYWORTH, et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Defendants and Respondents. No. A116798. Decided: July 25, 2008. Alioto Law Firm, Joseph M. Alioto, Theresa D. Moore, Angelina Alioto-Grace, Joseph M. Alioto, Jr., Thomas P. Pier, San ...

scocal.stanford.edu/opinion/clayworth-v-pfizer-33875

Jul 12, 2010 ... Filed 7/12/10. IN THE SUPREME COURT OF CALIFORNIA JAMES CLAYWORTH et al., Plaintiffs and Appellants, S166435 v. Ct.App. 1/2 A116798 PFIZER, INC., et al., Alameda County Defendants and Respondents. ) Super. Ct. No. RG04172428 When a group of companies conspires to fix prices at higher ...

www.justice.gov/usao/ma/news/Pfizer/Pfizer%20Settlement%20Agreement.pdf

Robert A. Liter v. Pfizer,. Civ. No. 06-00176 (E.D. Ky.); and. (9) United States et al. ex rel, Stefan Kruszewski v. Pfizer, Inc.,. Civ. No. 07-4106 (E.D. Pa.). C. On such date as may be determined by the Court, Pfizer subsidiary Pharmacia &. Upjohn Company, Inc. (“Pharmacia”) will enter a plea of guilty pursuant to Fed. R. Crim.

www.crin.org/en/library/legal-database/rabi-abdullahi-v-pfizer-inc

Aug 8, 2016 ... UNITED STATES. Title: Rabi Abdullahi v Pfizer, Inc. Court: United States Court of Appeals for the Second Circuit. Citation: Docket Nos: 05-4863-cv (L), 05-6768-cv (CON). Date: 30 January 2009. Instrument(s) Cited: Alien Tort Statute, 28 U.S.C. § 1350. Connecticut Unfair Trade Practices Act Connecticut ...

www.law360.com/cases/53c59fb78074bd3ed1000001

Parties, docket activity and news coverage of federal case American Sales Company, LLC v. Pfizer, Inc. et al, case number 2:14-cv-00361, from Virginia Eastern Court.

www.law360.com/articles/925226/pfizer-la-end-neurontin-antitrust-suit-with-1m-in-naloxone

May 17, 2017 ... The case is State of Louisiana v. Pfizer Inc. et al., case number 638506, in the 19th Judicial District Court, Paris of East Baton Rouge, State of Louisiana. -- Additional reporting by Alex Lawson. Editing by Kelly Duncan. Update: This story has been updated to clarify which drug Pfizer is providing to first ...

www.lexisnexis.com/legalnewsroom/litigation/b/litigation-blog/archive/2014/06/02/pfizer-to-pay-325m-to-settle-neurontin-3rd-party-payer-antitrust-class-action.aspx

Jun 2, 2014 ... In 2005, Assurant Health and other third-party payers sued Pfizer, alleging off- label promotion and state antitrust and consumer protection violations (the Assurant Plaintiffs) (Assurant Health, Inc., et al. v. Pfizer Inc., et al., No. 05-10535, D. Mass.). At the time the complaints were filed, Neurontin was ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4235474

Nov 13, 2014 ... Trough concentrations and AXA were lower for rivaroxaban (10 ng/mL and 0.17 IU/mL vs 17 ng/mL and 0.24 IU/mL for apixaban, respectively). .... at Intertek Pharmaceutical Services (formerly known as Alta Analytical Laboratory, El Dorado Hills, CA, USA) and at PPD Inc. (Middleton, WI, USA), respectively.

investors.pfizer.com/investor-news/press-release-details/2017/THE-UNION-FOR-INTERNATIONAL-CANCER-CONTROL-AND-PFIZER-AWARD-NEW-ROUND-OF-GRANTS-TOTALLING-US500000-TO-ORGANISATIONS-IN-19-COUNTRIES-TO-ADDRESS-THE-NEEDS-OF-METASTATIC-BREAST-CANCER-PATIENTS-WORLDWIDE/default.aspx

Oct 13, 2017 ... 3 Dowsett M, et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta- analysis of the randomised trials. Lancet. 2015;386(10001):1341-1352. 4 Cardoso F, Costa A, Norton L, et al. 1st International consensus ...